HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 61 | 63 | 96.8% | |
| HF004 | 2020 | 79 | 84 | 94.0% | |
| HF006 | 2021 | 113 | 136 | 83.1% | |
| HF006 | 2022 | 179 | 185 | 96.8% | |
| HF006 | 2023 | 192 | 197 | 97.5% |
